FDA Approved: BRIELLYN — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

The FDA approved a supplemental application for BRIELLYN, a norethindrone and ethinyl estradiol oral contraceptive from Glenmark Pharmaceuticals Inc., USA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contraception

Drugs mentioned

• BRIELLYN (NORETHINDRONE AND ETHINYL ESTRADIOL)

Snippet

SUPPL AP for BRIELLYN (NORETHINDRONE AND ETHINYL ESTRADIOL)